Huntington Ingalls Industries, Inc.
—- Market cap
- $11.10B
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HII stock price vs NOC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NOC's multiple
Needs NOC P/E.
Implied fair value · at HII's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HUNTINGTON INGALLS INDUSTRIES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
NORTHROP GRUMMAN CORP /DE/ · implied price per share
Bear
$125.92
Base
$162.13
Bull
$209.29
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe HII’s faster revenue growth can translate into sustained margin expansion toward NOC’s levels, then holding or accumulating HII makes sense because its lower P/S and EV/EBITDA multiples leave room for re-rating; otherwise, the current -3.7% implied downside suggests limited valuation support.
On a P/E basis, HII trades slightly richer than NOC at 19.3x versus 18.5x, yet on asset- and cash-flow-proxy multiples it is meaningfully cheaper, with P/S at 0.9x versus 1.8x, EV/EBITDA at 10.5x versus 15.7x, and EV/Revenue at 1.1x versus 2.1x. The model-implied price of $285.37 is modestly below the current price of $296.41, indicating a -3.7% downside and suggesting the market is not pricing in a large discount here.
Supporting Metrics